Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Sealdin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

85 API Suppliers, 28 USDMF, 27 CEP/COS, 7 JDMF, 15 EU WC, 18 KDMF, 17 NDC API, 37 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

53 Drugs in Development

53 Drugs in Development

INTERMEDIATES

19 Intermediate Suppliers

19 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

675 FDF Dossiers, 98 FDA Orange Book, 368 Europe, 57 Canada, 68 Australia, 25 South Africa, 59 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG BASE, TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 200MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 25MG BASE, TABLET;ORAL - EQ 50MG BASE

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 SPI Pharma, 5 DKSH, 6 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 1 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 23 BASF, 1 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 2 Finar, 12 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures, 4 Ingredion Pharma Solutions, 21 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 4 Silverline Chemicals, 1 Symrise, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

61 Fillers, Diluents & Binders, 47 Coating Systems & Additives, 28 Disintegrants & Superdisintegrants, 27 Direct Compression, 26 Controlled & Modified Release, 26 Solubilizers, 25 Granulation, 23 Thickeners and Stabilizers, 21 Topical, 19 Film Formers & Plasticizers, 17 Parenteral, 16 Lubricants & Glidants, 13 Co-Processed Excipients, 8 Emulsifying Agents, 8 Taste Masking, 7 Rheology Modifiers, 7 Chewable & Orodispersible Aids, 7 API Stability Enhancers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 Coloring Agents

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 31 News #PharmaBuzz

GLOBAL SALES INFORMATION

19 US Medicaid Prescriptions, 127 Regulatory FDF Prices, 10 Annual Reports

MARKET PLACE

20 APIs, 6 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Exclusivities, 5 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 2 USP, 14 Others

ANALYTICAL

1 Analytical Methods

1 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Amoli Organics	India	AMOLI ORGANICS PRIVATE LIMITED Mumbai IN	CEP 2021-424 - Rev 01	Sertraline hydrochloride, Form-I	2024-11-15	Valid	Chemical		1705
29/11/2025	Aurobindo Pharma Limited	India	APITORIA PHARMA PRIVATE LIMITED Hyderabad IN	CEP 2008-019 - Rev 06	Sertraline hydrochloride, Form I	2024-12-02	Valid	Chemical		1705

Sealdin

Sealdin

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

85 API Suppliers

28 USDMF

27 CEP/COS

7 JDMF

15 EU WC

18 KDMF

17 NDC API

37 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

53 Drugs in Development

INTERMEDIATES

19 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

675 FDF Dossiers

98 FDA Orange Book

368 Europe

57 Canada

68 Australia

25 South Africa

59 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG BASE

TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 200MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 25MG BASE

TABLET;ORAL - EQ 50MG BASE

RELATED EXCIPIENT COMPANIES

2 EUROAPI

4 SPI Pharma

5 DKSH

6 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

6 Nanjing Well Pharmaceutical

1 Kirsch Pharma

1 ACG Worldwide

7 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

23 BASF

1 Clariant

10 Corel Pharma Chem

6 DFE Pharma

1 Esteem Industries

2 Finar

12 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

5 Ideal Cures

4 Ingredion Pharma Solutions

21 Kerry

3 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

12 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

4 Novo Excipients

3 Pharmatrans-Sanaq

6 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

18 Roquette

13 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

11 Sigachi Industries

4 Silverline Chemicals

1 Symrise

2 The Dow Chemical Company

TABLET;ORAL - EQ 150MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 200MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons